
Anne Marie Sabrina Wehbe
Examiner (ID: 18312)
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1632, 1633, 1634 |
| Total Applications | 1342 |
| Issued Applications | 603 |
| Pending Applications | 239 |
| Abandoned Applications | 542 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9383405
[patent_doc_number] => 20140086886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'Stem Cell, Precursor Cell, or Target Cell-Based Treatment of Multi-Organ Failure and Renal Dysfunction'
[patent_app_type] => utility
[patent_app_number] => 14/030859
[patent_app_country] => US
[patent_app_date] => 2013-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13933
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14030859
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/030859 | Stem Cell, Precursor Cell, or Target Cell-Based Treatment of Multi-Organ Failure and Renal Dysfunction | Sep 17, 2013 | Abandoned |
Array
(
[id] => 10323618
[patent_doc_number] => 20150208622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-30
[patent_title] => 'GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/420318
[patent_app_country] => US
[patent_app_date] => 2013-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 18826
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14420318
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/420318 | Genetically modified non-human animals and methods of use thereof | Sep 5, 2013 | Issued |
Array
(
[id] => 9294045
[patent_doc_number] => 20140037679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'Immunization of avians by administration of non-replicating vectored vaccines'
[patent_app_type] => utility
[patent_app_number] => 14/020024
[patent_app_country] => US
[patent_app_date] => 2013-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27913
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14020024
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/020024 | Immunization of avians by administration of non-replicating vectored vaccines | Sep 5, 2013 | Issued |
Array
(
[id] => 9263366
[patent_doc_number] => 20130345295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'TARGETED ONCOLYTIC ADENOVIRUS FOR TREATMENT OF HUMAN TUMORS, CONSTRCUTION METHOD AND APPLICATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/016149
[patent_app_country] => US
[patent_app_date] => 2013-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 3919
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14016149
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/016149 | TARGETED ONCOLYTIC ADENOVIRUS FOR TREATMENT OF HUMAN TUMORS, CONSTRCUTION METHOD AND APPLICATION THEREOF | Sep 1, 2013 | Abandoned |
Array
(
[id] => 13746749
[patent_doc_number] => 10166299
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-01
[patent_title] => AAV mediated aquaporin gene transfer to treat Sjogren's syndrome
[patent_app_type] => utility
[patent_app_number] => 14/423774
[patent_app_country] => US
[patent_app_date] => 2013-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 13698
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14423774
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/423774 | AAV mediated aquaporin gene transfer to treat Sjogren's syndrome | Aug 29, 2013 | Issued |
Array
(
[id] => 10333226
[patent_doc_number] => 20150218230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'METHODS FOR MODULATING TAL SPECIFICITY'
[patent_app_type] => utility
[patent_app_number] => 14/424757
[patent_app_country] => US
[patent_app_date] => 2013-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 32524
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14424757
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/424757 | Methods for modulating TAL specificity | Aug 29, 2013 | Issued |
| 13/975179 | ANIMAL MODELS OF AGE-RELATED DISORDERS AND AGE-SENSITIVE TRAITS ASSOCIATED WITH SENESCENCE-INDUCING STIMULI AND USES THEREOF | Aug 22, 2013 | Abandoned |
| 13/975217 | ANIMAL MODELS FOR CANCER AND USES THEREOF | Aug 22, 2013 | Abandoned |
Array
(
[id] => 13127485
[patent_doc_number] => 10081663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-25
[patent_title] => Affinity maturated T cell receptors and use thereof
[patent_app_type] => utility
[patent_app_number] => 13/958277
[patent_app_country] => US
[patent_app_date] => 2013-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 55
[patent_no_of_words] => 20903
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13958277
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/958277 | Affinity maturated T cell receptors and use thereof | Aug 1, 2013 | Issued |
Array
(
[id] => 10290959
[patent_doc_number] => 20150175958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'CELL LINE DERIVED FROM THREAD-SAIL FILEFISH (STEPHANOLEPIS CIRRHIFER)'
[patent_app_type] => utility
[patent_app_number] => 14/418781
[patent_app_country] => US
[patent_app_date] => 2013-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 16444
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14418781
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/418781 | Cell line derived from thread-sail filefish (Stephanolepis cirrhifer) | Jul 29, 2013 | Issued |
Array
(
[id] => 9148313
[patent_doc_number] => 20130302836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'COMMON LIGHT CHAIN MOUSE'
[patent_app_type] => utility
[patent_app_number] => 13/948818
[patent_app_country] => US
[patent_app_date] => 2013-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 21712
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13948818
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/948818 | COMMON LIGHT CHAIN MOUSE | Jul 22, 2013 | Abandoned |
Array
(
[id] => 13196477
[patent_doc_number] => 10113148
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-30
[patent_title] => Method for obtaining monocytes or NK cells
[patent_app_type] => utility
[patent_app_number] => 14/414377
[patent_app_country] => US
[patent_app_date] => 2013-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 6679
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14414377
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/414377 | Method for obtaining monocytes or NK cells | Jul 9, 2013 | Issued |
Array
(
[id] => 9410534
[patent_doc_number] => 20140101786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-10
[patent_title] => 'GENERATION OF AUTOLOGOUS T-CELLS IN MICE'
[patent_app_type] => utility
[patent_app_number] => 13/931659
[patent_app_country] => US
[patent_app_date] => 2013-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 80
[patent_figures_cnt] => 80
[patent_no_of_words] => 65188
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13931659
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/931659 | Generation of autologous T-cells in mice | Jun 27, 2013 | Issued |
Array
(
[id] => 10288336
[patent_doc_number] => 20150173333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'RAPID SPECIFIC PATHOGEN FREE ANIMAL'
[patent_app_type] => utility
[patent_app_number] => 14/408799
[patent_app_country] => US
[patent_app_date] => 2013-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 20726
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14408799
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/408799 | RAPID SPECIFIC PATHOGEN FREE ANIMAL | Jun 24, 2013 | Abandoned |
Array
(
[id] => 10288332
[patent_doc_number] => 20150173330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'MOUSE MODEL OF AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL LOBAR DEGENERATION'
[patent_app_type] => utility
[patent_app_number] => 14/404570
[patent_app_country] => US
[patent_app_date] => 2013-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6212
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404570
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/404570 | MOUSE MODEL OF AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL LOBAR DEGENERATION | May 29, 2013 | Abandoned |
Array
(
[id] => 9222438
[patent_doc_number] => 20140017213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'Engineering and Delivery of Therapeutic Compositions of Freshly Isolated Cells'
[patent_app_type] => utility
[patent_app_number] => 13/902444
[patent_app_country] => US
[patent_app_date] => 2013-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 15126
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13902444
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/902444 | Engineering and delivery of therapeutic compositions of freshly isolated cells | May 23, 2013 | Issued |
Array
(
[id] => 9068163
[patent_doc_number] => 20130259919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'SURGICAL DEVICE FOR SKIN THERAPY OR TESTING'
[patent_app_type] => utility
[patent_app_number] => 13/901728
[patent_app_country] => US
[patent_app_date] => 2013-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6006
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13901728
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/901728 | Surgical device for skin therapy or testing | May 23, 2013 | Issued |
Array
(
[id] => 10318866
[patent_doc_number] => 20150203869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-23
[patent_title] => 'Adenoviral Vectors for Transduction of Vascular Tissue'
[patent_app_type] => utility
[patent_app_number] => 14/402791
[patent_app_country] => US
[patent_app_date] => 2013-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9877
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402791
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/402791 | Adenoviral vectors for transduction of vascular tissue | May 22, 2013 | Issued |
Array
(
[id] => 9265209
[patent_doc_number] => 20130347138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'Cells and Vertebrates for Enhanced Somatic Hypermutation and Class Switch Recombination'
[patent_app_type] => utility
[patent_app_number] => 13/890147
[patent_app_country] => US
[patent_app_date] => 2013-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 28832
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13890147
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/890147 | Cells and Vertebrates for Enhanced Somatic Hypermutation and Class Switch Recombination | May 7, 2013 | Abandoned |
Array
(
[id] => 14948819
[patent_doc_number] => 10435669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-08
[patent_title] => Bacteriophage for biocontrol of
[patent_app_type] => utility
[patent_app_number] => 14/399383
[patent_app_country] => US
[patent_app_date] => 2013-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 17
[patent_no_of_words] => 22948
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399383
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/399383 | Bacteriophage for biocontrol of | May 6, 2013 | Issued |